Company Filing History:
1 out of 4 
1 out of 1,291 
Years Active: 2020
Title: Katharina Ramoni: Innovator in Monoclonal Antibody Development
Introduction
Katharina Ramoni is a distinguished inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work has led to the creation of a patent that addresses critical aspects of immunology.
Latest Patents
Katharina holds a patent for O3 specific antibodies. This invention involves a cross-neutralizing monoclonal antibody that specifically recognizes a cross-reactive epitope of the lipopolysaccharide (LPS) antigen structure. The patent details the O3b epitope, which cross-reacts with both the O3a and O3 epitopes. The antibody is characterized by specific CDR sequences or VH and VL sequences, showcasing her expertise in antibody engineering.
Career Highlights
Throughout her career, Katharina has worked with notable organizations such as Arsanis Biosciences GmbH and the Max Planck Society for the Advancement of Science. Her experience in these institutions has allowed her to refine her skills and contribute to groundbreaking research in the field of immunology.
Collaborations
Katharina has collaborated with esteemed colleagues, including Valeria Szijárto and Gábor Nagy. These partnerships have further enhanced her research and development efforts, leading to advancements in antibody technology.
Conclusion
Katharina Ramoni is a remarkable inventor whose work in monoclonal antibodies has the potential to impact various fields, including medicine and biotechnology. Her innovative spirit and dedication to research continue to inspire future advancements in immunology.